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he mechanism by which the 
 
 
 
-cell transcription factor
Pax4 inﬂuences cell function/mass was studied in
rat and human islets of Langerhans. Pax4 transcripts
were detected in adult rat islets, and levels were induced
by the mitogens activin A and betacellulin. Wortmannin
suppressed betacellulin-induced Pax4 expression, impli-
cating the phosphatidylinositol 3-kinase signaling pathway.
Adenoviral overexpression of Pax4 caused a 3.5-fold
increase in 
 
 
 
-cell proliferation with a concomitant 1.9-, 4-,
and 5-fold increase in Bcl-xL (antiapoptotic), c-myc,
and Id2 mRNA levels, respectively. Accordingly, Pax4
T
 
transactivated the Bcl-xL and c-myc promoters, whereas
its diabetes-linked mutant was less efﬁcient. Bcl-xL activity
resulted in altered mitochondrial calcium levels and ATP
production, explaining impaired glucose-induced insulin
secretion in transduced islets. Infection of human islets
with an inducible adenoviral Pax4 construct caused
proliferation and protection against cytokine-evoked ap-
optosis, whereas the mutant was less effective. We pro-
pose that Pax4 is implicated in 
 
 
 
-cell plasticity through
the activation of c-myc and potentially protected from
apoptosis through Bcl-xL gene expression.
 
Introduction
 
Diabetes mellitus comprises a heterogeneous group of hyper-
glycemic disorders resulting from inadequate mass and function
of pancreatic islet 
 
 
 
-cells. Two studies have associated mutations
in the 
 
pax4
 
 gene to type 2 diabetes in the Japanese population,
while two haplotypes of this gene have been linked to type 1
diabetes in Scandinavian families (Shimajiri et al., 2001, 2003;
Kanatsuka et al., 2002; Holm et al., 2004). The functional role
of Pax4 in 
 
 
 
-cell physiology, and thus its potential implication
in diabetes, is still poorly understood. Pax4 is detected in the
pancreatic bud at mouse embryonic day 9.5, but expression
becomes progressively restricted to the 
 
 
 
- and 
 
 
 
-cells of the
islet of Langerhans, producing, respectively, insulin and soma-
tostatin (Sosa-Pineda et al., 1997). Several independent studies
have detected Pax4 mRNA in adult human, rat, and mouse pan-
creatic islets (Heremans et al., 2002; Kojima et al., 2003;
Zalzman et al., 2003). Targeted disruption of the 
 
pax4
 
 gene in
mice results in the absence of mature pancreatic 
 
 
 
- and 
 
 
 
-cells
with a commensurate increase in glucagon-containing 
 
 
 
-cells
(Sosa-Pineda et al., 1997). However, the earliest insulin-producing
precursor cells, detected at embryonic day 8.5–9 (Gittes and
Rutter, 1992), are present, indicating that Pax4 expression is
not mandatory for the generation of 
 
 
 
-cell precursors but rather
is critical for the proliferation and/or survival of these cells
(Sosa-Pineda et al., 1997). Accordingly, elevated expression
levels of Pax4 mRNA are found in human insulinomas (Mi-
yamoto et al., 2001).
To better understand the impact of Pax4 in 
 
 
 
-cell function,
pharmacological and molecular studies were performed on
isolated rat islets. Our work suggests that mitogens such as
betacellulin activate Pax4 through the phosphatidylinositol
3-kinase (PI3-kinase) pathway. Furthermore, we found that
forced expression of Pax4 stimulates 
 
 
 
-cell proliferation and
survival through concomitant regulation of the oncogene c
 
-myc
 
and the antiapoptotic gene 
 
bcl-xl
 
. In contrast, the diabetes-
linked mutant R129W elicited an attenuated response. Consistent
with Bcl-xL induction, mitochondrial function such as ATP
production and Ca
 
2
 
 
 
 homeostasis was altered, resulting in
curtailed glucose-induced insulin secretion. Similarly, human
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islets transduced with a novel doxycycline-inducible adenoviral
construct harboring the mouse Pax4 cDNA exhibited graded
proliferation and protection against apoptosis, whereas the dia-
betes-linked mutant conferred a modest effect. Together, these
findings suggest that Pax4 participates in the regulation of
 
 
 
-cell plasticity and that loss-of-function mutations result in the
gradual loss of insulin-producing cells, and ultimately diabetes.
 
Results
 
Activin A and betacellulin increase Pax4 
gene transcription as well as 
 
 
 
-cell 
proliferation in rat islets
 
Basal mRNA expression levels for Pax4 were established in is-
lets and found to give a relative abundance value of 4.7 when
normalized to the housekeeping transcript cyclophilin. In con-
trast, Pax4 mRNA was barely detectable in rat liver cells.
The ubiquitously expressed mitochondrial transcription factor
TFAM was found with similar relative abundance of 5 and 6.5
in liver and islets, confirming tissue-specific expression of Pax4
in mature islets (Fig. 1 A). Of note, Pax4 mRNA was 25-fold
higher in the insulin-producing INS-1E cell line (unpublished
data), which is consistent with elevated expression levels de-
tected in human insulinomas (Miyamoto et al., 2001). The re-
sponses of the 
 
pax4
 
 gene to activin A (a member of the TGF-
 
 
 
family) and betacellulin (a member of the EGF family) were in-
vestigated in rat islets (Demeterco et al., 2000). Treatment of is-
lets for 24 h with a range of concentrations resulted in a dose-
dependent increase of Pax4 mRNA levels. Maximal induction was
observed with 0.5 nM of activin A or betacellulin that elicited a
4.3- and 4.2-fold increase in Pax4 mRNA, respectively (Fig. 1 B).
As in insulinoma cells (Ueda, 2000), the related factor TGF-
 
 
 
1
had no significant effect on Pax4 expression in islets. Of note,
insulin mRNA levels were unaffected by both treatments (un-
published data). The main intracellular signaling step of betacel-
lulin via interaction with the EGF receptor is the activation of
PI3-kinase. To elucidate whether or not this pathway, which has
been shown to promote 
 
 
 
-cell replication (Buteau et al., 2003),
was also involved in Pax4 activation, islets were incubated with
the PI3-kinase inhibitor wortmannin. The inhibitor (100 nM) al-
most completely abolished betacellulin-induced 
 
pax4
 
 gene ex-
pression, suggesting that the transcription factor is a down-
stream target of the PI3-kinase (Fig. 1 C). In parallel, we
confirmed the mitogenic effect of activin A and betacellulin by
Figure 1. Activin A and betacellulin increase Pax4
mRNA levels as well as  -cell proliferation in rat islets.
(A) Pax4 is expressed in adult rat islets but not in the
liver. Quantitative RT-PCR using RNA purified from
freshly isolated islets and hepatocytes were per-
formed on Pax4 and TFAM. Data are presented as
relative mRNA abundance levels normalized to the
transcript cyclophilin and represent the mean   SEM
of six independent experiments performed in triplicates.
A representative agarose gel depicting the amplified
Pax4 transcript is shown on the right. The fragment
was subcloned and confirmed to be Pax4 by se-
quencing. White line indicates that intervening lanes
have been spliced out. (B) PAX4 mRNA levels in islets
treated with increasing doses of activin A, betacellulin,
or TGF- 1 as indicated. (C) Islets were incubated with
0.5 nM of betacellulin in the absence or presence of
50 and 100 nM of the PI3-kinase inhibitor wortmannin.
Pax4 transcript abundance levels were estimated by
quantitative RT-PCR. (D)  -Cell proliferation was
measured by BrdU incorporation in islets treated with
the indicated growth factors at 0.5 nM. Data repre-
sent the mean   SEM of four independent experi-
ments, comprising more than 900 cells per condition.
Statistical significance was tested by t test. *, P  
0.05; **, P   0.01. 
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measuring 
 
 
 
-cell replication using BrdU incorporation. Both
growth factors (at 0.5 nM) increased 
 
 
 
-cell proliferation by ap-
proximately threefold, whereas TGF-
 
 
 
1–treated islets remained
quiescent (Fig. 1 D). Together, these results suggest that stimu-
lation of Pax4 gene expression by activin A and betacellulin co-
incides with islet proliferation induced by the two mitogens.
 
Adenovirus-mediated Pax4 
overexpression in rat pancreatic islets 
induces 
 
 
 
-cell proliferation
 
To evaluate the importance of Pax4 in 
 
 
 
-cell replication, isolated
islets were infected with a CMV promoter–driven Pax4/GFP-
expressing adenovirus (AdCMVPax4IRESGFP) or control ade-
novirus (AdCAlacZ). Because the antibody against Pax4 is un-
able to detect the protein by immunohistochemistry or by West-
ern blotting (unpublished data), we monitored its overexpression via
the reporter GFP cotranslated from a bi-cistronic transcript. Ap-
proximately 25% and 50% of 
 
 
 
-cells expressed GFP 48 h after
infection with 1 and 2.4 
 
 
 
 10
 
7
 
 pfu/ml of AdCMVPax4IRESGFP,
respectively (Fig. 2 A). Pax4 transcript was estimated to reach
levels 22 
 
 
 
 fivefold higher (
 
n 
 
  
 
3) than those found in control
AdCALacZ-infected islets (unpublished data). Like mitogen-
stimulated islets, insulin mRNA levels (Fig. 3 C) were un-
changed, indicating that Pax4 overexpression did not alter the
phenotypic profile of the 
 
 
 
-cell. Production of a functional
protein was confirmed by electrophoretic mobility shift assay
Figure 2. AdCMVPax4IRESGFP-transduced
rat islets express Pax4 and exhibit increased
 -cell replication. (A) Immunofluorescent de-
tection of EGFP (green) and insulin (red) as
well as DAPI nuclei staining (blue) in dispersed
islet cells 48 h after infection with the indi-
cated doses of adenovirus. Pax4 is identified
via the reporter cotranslated EGFP in insulin-
positive cells (arrows). (B) EMSA using a radio-
labeled G3 element of the glucagon gene
promoter and full-length mouse Pax4, pro-
duced by the coupled TNT system (lanes 1–3),
as well as 6  g of nuclear protein extracts from
infected rat islets (lanes 4–8). Infection for 48 h
with the indicated amounts of the adenovirus
increased Pax4 DNA binding activity to the
G3 element in a dose-dependent manner
(lanes 5–7). The asterisk delineates the formation
of a supershift complex in the presence of anti-
Pax4 serum (lanes 2 and 8). White line indicates
that intervening lanes have been spliced out.
(C)  -Cell proliferation was measured by BrdU
incorporation in islets infected either with Ad-
CaLacZ or AdCMVPax4IRESGFP (2.4   10
7
pfu/ml). A representative composite image of
an islet immunostained for BrdU (green), insulin
(red), and DAPI (blue) is shown. (D) Dispersed
 -cells immunostained for both insulin and
BrdU were counted under a fluorescent micro-
scope and results are depicted as a percent-
age of BrdU/insulin-positive cells over the total
amount of insulin-positive cells. Data show the
mean   SEM of five independent experiments,
each representing more than 1,000 cells per
condition. **, P   0.01. Bars, 50  M. 
JCB • VOLUME 167 • NUMBER 6 • 2004 1126
 
(EMSA) using a cognate radiolabeled G3 element of the gluca-
gon gene promoter (Ritz-Laser et al., 2002). A single complex
previously identified as Pax6 (Ritz-Laser et al., 2002) was ob-
served in nuclear extracts derived from AdCaLacZ-infected islets
(Fig. 2 B, lane 4). An additional complex of similar migration pat-
tern to that produced by recombinant Pax4 was generated in islets
infected with increasing amounts of AdCMVPax4IRESGFP (Fig.
2 B, lanes 1 and 5–7). This complex was supershifted by the Pax4
antiserum, confirming the binding of Pax4 to this site (Fig. 2 B,
lane 2 and 8). The capacity of Pax4 to promote islet proliferation
was then evaluated by BrdU incorporation (Fig. 2 C). Quantifica-
tion revealed a 3.5-fold increase in BrdU labeling of 
 
 
 
-cells ex-
pressing Pax4 as compared with AdCALacZ-transduced islets. In
contrast, proliferation was unaffected by overexpression of Pax6
and neurogenin3, confirming the specificity of Pax4-associated
 
 
 
-cell replication (Fig. 2 D). Thus, forced expression of Pax4 spe-
cifically induced DNA synthesis in 
 
 
 
-cells, recapitulating the ef-
fect observed with both activin A and betacellulin.
 
Pax4 induces genes implicated in 
proliferation and survival
 
The c
 
-myc
 
 oncogene was shown to be an important regulator of
both cell proliferation and apoptosis in mouse islet 
 
 
 
-cells (Pe-
lengaris et al., 2002). Thus, a temporal expression profiling of
this factor was performed in rat islets infected for up to 6 d with
either AdCMVPax4IRESGFP or AdCaLacZ. EMSA revealed a
transient Pax4 DNA binding activity to the G3 element reaching
maximal levels 1 d after infection with AdCMVPax4IRESGFP
and returning to low levels by day 6 (Fig. 3 A). In parallel,
c-myc mRNA levels were induced fourfold in Pax4-expressing
islets 24 and 96 h after infection as compared with correspond-
ing time points of cells expressing LacZ (Fig. 3 B). Because
c-myc stimulates proliferation through activation of the Id2 cell
cycle progression regulator, we explored whether or not this
pathway was triggered in Pax4-overexpressing islets (Lasorella
et al., 2000). As anticipated, the c-myc target Id2 was increased
5-fold in AdCMVPax4IRESGFP-transduced islets as compared
Figure 3. Time-dependent gene expression
profiling of Pax4-overexpressing islets. (A) EMSA
using 6  g of nuclear protein extracts from
AdCMVPax4IRESGFP-transduced rat islets cul-
tured in RPMI 1640 medium over a period of 6 d.
Pax4 DNA binding activity to the G3 element is
maximal 1 d after infection. The asterisk repre-
sents the supershifted complex in the presence of
anti-Pax4 serum. (B and C) Quantitative RT-PCR
analysis performed on RNA isolated from AdCa-
LacZ (LacZ;  )- and AdCMVPaxIRESGFP (PAX4;
 )-infected islets (2.4   10
7 pfu/ml, 50% infectibil-
ity). Transcript levels were grouped into four cate-
gories: proliferative genes comprising c-myc
and Id2; apoptotic genes composed of Bcl-xL,
Bcl-2,  and  caspase-3; the transcription factor
Pdx-1; and endocrine hormone genes compris-
ing insulin, glucagon, and somatostatin. Expres-
sion patterns were measured over a period of 6 d.
Each value represents mean   SEM of three in-
dependent experiments. Statistical significance
was tested between LacZ- and PAX4-infected islets
by unpaired t test. *, P   0.05; **, P   0.01. 
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with those detected in control 4 d after infection (Fig. 3 B).
Bcl-xL was shown to prevent c-myc–induced 
 
 
 
-cell apoptosis
and to promote proliferation by suppressing the mitochondrial
apoptotic pathway (Pelengaris et al., 2002). A similar phenome-
non was reported in a mouse model recapitulating human
plasma cell neoplasms (Cheung et al., 2004), indicating an inti-
mate coupling between c
 
-myc
 
 and 
 
bcl-xl
 
 gene expression in pro-
moting proliferation and survival. Consistent with this hypoth-
esis, expression levels of Bcl-xL were found to be 2.2- and
1.9-fold higher in Pax4-expressing cells 24 and 96 h after infec-
tion. Caspase-3 mRNA levels remained constant for the dura-
tion of the experiment, whereas Bcl-2 mRNA levels were tran-
siently induced (Fig. 3 B). These results suggest that Pax4 may
stimulate 
 
 
 
-cell proliferation through the activation of the
c-myc–Id2 pathway and potentially Bcl-xL gene expression.
 
Hormone expression profiling of 
AdCMVPax4IRESGFP-infected islets
 
Pax4 was reported to inhibit expression of insulin and glucagon
in various 
 
 
 
 and 
 
 
 
 cell lines (Campbell et al., 1999; Ritz-Laser
et al., 2002). We found that insulin, glucagon, and somatostatin
mRNA levels were unaltered in AdCMVPax4IRESGFP-infected
 
Table I. 
 
Insulin and glucagon protein contents in Pax4-overexpressing 
islets
Insulin Glucagon
 
ng/islet ng/islet
 
Control 58.3 
 
 
 
 2.4 1.0 
 
 
 
 0.3
AdCALacZ 42.3 
 
 
 
 0.8  1.1 
 
 
 
 0.1
AdCMVPax4IRESGFP
1 
 
 
 
 10
 
7
 
59.5 
 
 
 
 2.2 1.0 
 
 
 
 0.2
2.4 
 
 
 
 10
 
7
 
74.9 
 
 
 
 3.3 1.1 
 
 
 
 0.2
 
Total insulin and glucagon protein contents were quantified by radioimmunoassay
48 h after infection, and results were expressed as nanograms of protein per islet.
Data show the mean 
 
  SEM of three independent experiments. Statistical
significance was tested between control and PAX4-infected islets (2.4   10
7 pfu/ml)
by unpaired t test and was found to be P   0.01.
Figure 4. Analysis of the expression and
function of Pax4 wt and its mutant R129W.
(A) Immunofluorescent detection of the myc-
tagged Pax4 or synaptotagmin VII proteins
(red) and DAPI nuclei staining (blue) in INS-1E
cells 48 h after transfection with the indicated
constructs. Pax4 and synaptotagmin VII were
detected via the myc epitope in the nuclei and
cytoplasm of INS-1E cells, respectively. (B)
EMSA using the G3 element and the recombi-
nant proteins Pax4-myc wt (lanes 1 and 2)
and Pax4-myc R129W (lanes 3 and 4). An
equal amount of protein was applied in each
lane (see Fig. 4 C). Pax4 wt bound to the G3
element (lane 1), whereas the binding of the
R129W mutant was less efficient (lane 3). The
asterisk delineates the formation of a super-
shift complex due to the addition of anti-myc
epitope antibody (lanes 2 and 4). (C) Western
blotting of the recombinant proteins Pax4-myc
wt and R129W using an anti-myc epitope
antibody. (D) Effects of Pax4-myc wt ( ) and
its mutant R129W ( ) on the human c-myc
and murine Bcl-xL promoters. Cotransfection
studies using BHK-21 cells were performed
with increasing amounts of wt and R129W
Pax4. The telomerase promoter construct ( )
was used as a negative control. The pSV- -
galactosidase control vector was used as inter-
nal control to normalize for transfection effi-
ciency ( 15%). Data are presented as fold
induction of basal luciferase activity and ex-
pressed as the mean   SEM of four to five in-
dependent experiments. *, P   0.05, for com-
parison between Pax4 wt and R129W for
each of the promoter constructs. Bar, 50  M.JCB • VOLUME 167 • NUMBER 6 • 2004 1128
islets for up to 6 d after transduction (Fig. 3 C). Consistent with
these findings, mRNA levels for the transcription factor Pdx1,
a major stimulator of insulin and somatostatin gene transcrip-
tion, also remained stable (Fig. 3 C). Glucagon and insulin pro-
tein contents were next determined by radioimmunoassay 48 h
after infection. A small but significant increase in insulin pro-
tein content was measured in islets transduced with the highest
concentration of AdCMVPax4IRESGFP, whereas glucagon
protein levels remained constant (Table I). This increase in in-
sulin could be attributed to Pax4-induced increase in cell num-
ber as mRNA levels for the hormone remained constant. Thus,
Pax4 does not function as a transcriptional repressor of insulin
and glucagon in mature islet cells.
Pax4 transactivates both the c-myc and 
Bcl-xL gene promoter
To examine whether or not Pax4 is involved in the regulation of
c-myc and Bcl-xL transcription, transient transfection assays
were performed in BHK-21 cells with luciferase reporter con-
structs harboring either gene promoter along with increasing
amounts of Pax4. The impact of the type 2 diabetes–associated
Pax4 mutation R129W, located in the paired DNA binding do-
main, was also evaluated (Shimajiri et al., 2001). We generated
two expression vectors containing either a wild type (wt; Pax4-
myc wt) or mutant Pax4 (Pax4-myc R129W) cDNA fused to the
myc epitope. We first validated expression and localization of
the proteins encoded by the two constructs in rat insulinoma
INS-1E cells. Immunofluorescence using a myc antibody re-
vealed nuclear localization of Pax4 (wt and mutant) in trans-
fected cells (Fig. 4 A). Transfection with the vesicular protein
synaptotagmin VII/myc tag resulted in cytoplasmic staining, in-
dicating that the epitope did not interfere with proper compart-
mentalization (Fig. 4 A, bottom). EMSA using equal amounts of
in vitro transcribed and translated recombinant proteins (verified
by Western blotting, Fig. 4 C) and the G3 element confirmed the
binding activity of the myc-fused wt and mutant Pax4 proteins
(Fig. 4 B, lanes 1 and 3). The specificity of the complex was
demonstrated by supershift assay using the myc antibody (Fig. 4
B, lanes 2 and 4). Interestingly, the G3 binding affinity of the
Pax4-myc R129W protein was much weaker than the Pax4-myc
wt. Transient transfections revealed that increasing amounts of
the Pax4-myc wt expression vector dose dependently stimulated
luciferase activity of the c-myc and Bcl-xL gene promoter con-
structs reaching up to 3.5- and 2.7-fold, respectively (Fig. 4 D).
However, Pax4-myc R129W was less efficient in transactivating
both constructs, reaching maximal induction levels of only
2.1- and 1.5-fold for the c-myc and Bcl-xL reporter constructs,
respectively (Fig. 4 C). Transactivation was promoter specific
because Pax4 was unable to induce the telomerase promoter
Tert-Luc (Fig. 4 D). These results indicate that Pax4 regulates
c-myc and Bcl-xL transcription, whereas the mutant form is less
efficient in stimulating the expression of the two genes.
Pax4 overexpression attenuates insulin 
secretion in islets
Although other antiapoptotic genes may be implicated in the
protection of c-myc–induced cell death, we pursued the poten-
tial protective function of Bcl-xL in view of its link with c-myc
in  -cell survival and proliferation (Pelengaris et al., 2002).
Small increases in Bcl-xL, similar to those observed in our
work, were shown to protect  -cells against thapsigargin-
induced apoptosis in a transgenic mouse model. Increased lev-
els of this mitochondrially targeted protein were also found to
impair insulin secretion (Zhou et al., 2000). Consistent with these
studies, we found that glucose-stimulated insulin exocytosis
was attenuated by 50% in Pax4-overexpressing islets 48 h after
infection.   -Galactosidase–expressing islets and noninfected
controls exhibited an expected threefold increase in hormone
release (Fig. 5 A). However, inhibition was transient as glu-
cose-induced insulin secretion was restored 6 d after infec-
tion (unpublished data). Inclusion of 1  M forskolin/100  M
IBMX, which modulates the effect of glucose on secretion by
raising cAMP levels, restored glucose-induced insulin exocyto-
sis, indicating that events downstream of plasma membrane de-
polarization are functional in Pax4-expressing cells. To evalu-
ate whether or not Pax4-induced Bcl-xL expression curtails the
Figure 5. Effects of Pax4 overexpression on insulin secretion and glucose
oxidation in isolated rat islets. (A) Glucose-induced insulin secretion was
inhibited by AdCMVPax4IRESGFP. 2 d after infection, islet hormone secretion
was assayed as described in Materials and methods. Data are expressed
as the mean   SEM of four independent experiments. **, P   0.01. (B) 2 d
after infection with 2.4   10
7 pfu/ml of indicated adenoviruses, islet CO2
generation was measured in the presence of 2.5 or 16.7 mM glucose to
assess glucose oxidation rate as described in the experimental procedures.
Data represent the mean   SEM of five independent experiments.PAX4 AND PANCREATIC  -CELL PLASTICITY • BRUN ET AL. 1129
metabolism–secretion coupling cascade, glucose metabolism as
well as ATP levels and mitochondrial calcium concentrations
([Ca
2 ]m) were measured in transduced islets. The rate of glu-
cose oxidation was estimated by measuring the conversion of
D-[
14C(U)] to 
14CO2 and found to be equally efficient in both
control and infected islets (Fig. 5 B). However, total cellular
ATP levels were fourfold higher in islets expressing Pax4 as
compared with control LacZ islets (Fig. 6 A). Cellular ATP lev-
els largely reflect sequestered pools in organelles, in particular
in the mitochondria (Detimary et al., 1995). These results
prompted us to investigate whether or not glucose was able to
raise cytosolic ATP levels in Pax4-overexpressing islets, which
are essential in the coupling of metabolism to insulin secretion
(Gauthier et al., 2004). Addition of 16.5 mM glucose to control/
LacZ islets resulted in a 23% increase of cytosolic ATP, which
was sustained until the injection of azide, a compound that dis-
sipates the mitochondrial membrane potential and thus inter-
rupts ATP formation (Fig. 6 B). Cytosolic ATP from islets
maintained in 2.5 mM glucose gradually decreased to levels
80% of those at time of glucose injection consistent with low
sustained energy consumption. Unexpectedly, basal cytosolic
ATP in AdCMVPax4IRESGFP-infected islets was 30% of that
measured in control islets, and a small nonsignificant increase
in production was detected after exposure to 16.5 mM glucose
(Fig. 6 B). Changes in cytosolic calcium are relayed to the mi-
tochondria (Kennedy et al., 1996; Ishihara et al., 2003). Rest-
ing [Ca
2 ]m was elevated in  -cells of Pax4-transduced islets,
nearly twofold higher than controls (Fig. 6 C). High concentra-
tions of extracellular potassium trigger calcium influx across
the plasma membrane independently of ATP production and
KATP channel closure. The potassium-induced rise in [Ca
2 ]m
was normal in transduced islets, as assessed by the total in-
crease in [Ca
2 ]m (area under peak [AUP]). However, the glu-
cose-induced increase in [Ca
2 ]m (AUP) was attenuated by
40   5% in Pax4-expressing islets. Together, these results indi-
cate that increased Pax4 expression provokes alterations in both
mitochondrial calcium levels and ATP synthesis, which may un-
derlie the blunted glucose-induced insulin secretion (Fig. 6 D).
Figure 6. Total cellular ATP and mitochondrial
calcium levels are increased in
AdCMVPax4IRESGFP-infected islets. (A) Total
cellular ATP levels were measured in islets
overexpressing either  -galactosidase or
PAX4 (2.4   10
7 pfu/ml, 50% of cell infected)
and maintained in 1 mM glucose for 10 min.
Results represent the means   SEM. **, P  
0.01. (B) Cytosolic ATP production in response
to 2.5 or 16.5 mM glucose was determined
over a period of 20 min using the ATP-sensitive
bioluminescence probe luciferase (3.6   10
7
pfu/ml). Glucose and azide were added at in-
dicated times (arrows). Results are the mean  
SEM of at least five experiments performed
in duplicates (*, P   0.05). (C) Mitochondrial
calcium was monitored in  -galactosidase or
PAX4 overexpressing islets using  -cell–specific/
mitochondrial-targeted aequorin as described
in Materials and methods. After the establish-
ment of baseline luminescence (30 min; LacZ  
210   49 nM and Pax4   387   46 nM,
left), islets were superfused for 5 min in basal
conditions (0 glucose) before stimulation with
glucose (16.7 mM), and then KCl (60 mM) for
5 min intervals each, as shown (middle). The
induced increases in [Ca
2 ]m were evaluated
on the basis of the AUP and a presented on
the right. Each value represents the mean  
SEM of a minimum of six separate experi-
ments. *, P   0.05. (D) Proposed model of
Pax4-induced   -cell proliferation. Mitogens
activate Pax4, which will stimulate c-myc and
Bcl-xL gene transcription. c-Myc will promote
Id2 gene expression and activate the cell cycle
replication program. Bcl-xL increased expression
will promote survival by preventing mitochon-
dria from initiating the apoptotic program.
However, cells become refractory to glucose-
evoked insulin secretion due to altered ATP
production and calcium handling.JCB • VOLUME 167 • NUMBER 6 • 2004 1130
Induction of Pax4 stimulates human islet 
 -cell proliferation and protects against 
apoptosis
Next, we assessed the impact of Pax4 and its mutant variant
R129W on human islet proliferation using novel doxycycline
inducible recombinant adenoviruses engineered to express
these proteins tagged to the myc epitope (Ad-mPax4-myc wt or
Ad-mPax4-myc R129W). In the absence of doxycycline, the
immunoreactive myc epitope was not detected in transduced
islet cells (Fig. 7 A). Addition of 0.5  g/ml doxycycline re-
sulted in the induction of mPax4-myc wt and R129W in the nu-
clei of  70% of islet cells (Fig. 7 A). Quantitative RT-PCR re-
vealed a 10- and 20-fold increase in Pax4 transcript in islets
treated with 0.5 and 1  g/ml doxycycline, respectively (unpub-
lished data). Similarly, a dose-dependent increase in Pax4 pro-
tein levels was detected by Western blotting using the myc
epitope antibody (Fig. 7 B). To achieve physiological levels of
Pax4, similar to those induced by mitogens, proliferation ex-
periments were performed using the lower concentration of
doxycycline (0.5  g/ml). No visible proliferation was detected
in the absence of doxycycline ( 1%). Concomitant with in-
duction of mPax4 wt expression,  10% of cells incorporated
BrdU, whereas only 2% of BrdU-positive cells were detected
in islets expressing Pax4 R129W (Fig. 8 A). Interestingly, 7%
of cells infected with Ad-mPax4-myc wt were BrdU and insu-
lin positive (as shown in a representative experiment in Fig. 8
B, bottom right arrow), consistent with values obtained in rat
islets (Fig. 2 D). However, an additional 3% were only BrdU
positive, indicating that other cell types may also be prone to
proliferation in the presence of Pax4 (Fig. 8 B, top left arrows).
To appraise the potential protective role conferred by Pax4-
induced Bcl-xL expression observed in rat islets, transduced
human islets were exposed to a mixture of cytokines (2 ng/ml
IFN- , IL-1 , and TNF- ) to induce apoptosis. Adenoviral-
infected islets in the absence of both doxycycline and cyto-
kines exhibited a 1.3-fold increase in apoptosis as compared
with control noninfected islets (Fig. 9, A and B). Treatment
with cytokines provoked a further 4.4-fold increase in cell
death. In contrast, Pax4 wt expression (induced by the two
concentrations of doxycycline) conferred complete protection
against apoptosis (Fig. 9 A). At the low dose of doxycycline,
the R129W mutation showed an attenuate protection against
cytokine-induced cell death (8.8% TUNEL-positive cells com-
pared with 4% in Pax4 wt; ANOVA: P   0.00245; Fig. 9 B).
Together, our results suggest that Pax4 promotes human islet
cell replication as well as conferring survival potentially through
the activation of Bcl-xL. The diabetes-linked mutant form of
Pax4 is incapable of reproducing these effects.
Figure 7. Pax4 and its diabetes-linked mutant
are induced by doxycycline in a dose-dependent
manner in human islets. (A) Islets were co-
infected with either Ad-mPax4-myc wt or
R129W as described in Materials and methods.
Doxycycline-dependent activation of PAX4 wt
and mutant was assessed 48 h later by immuno-
histochemistry; myc epitope (red), insulin
(green), and DAPI (blue). Arrows depict Pax4-
expressing  -cells. Pax4 was detected in the
nuclei of  70% of human islet cells cultured in
the presence of doxycycline, whereas no
basal induction of Pax4 was observed in the
absence of doxycycline. Bar, 50  M. (B)
Western blotting of nuclear extracts derived
from infected islet cells cultured in the presence
of 0 (lanes 1 and 4), 0.5 (lanes 3 and 6), and
1  g/ml (lanes 2 and 5) of doxycycline. The
same myc anti-serum was used for Western
blotting and immunofluorescence.PAX4 AND PANCREATIC  -CELL PLASTICITY • BRUN ET AL. 1131
Discussion
The endocrine pancreas is considered a dynamic tissue that un-
dergoes perpetual cell renewal (neogenesis and replication) as
well as apoptosis throughout a lifetime (Bonner-Weir, 2000;
Finegood et al., 2001; Dor et al., 2004). Although growth fac-
tors regulating both proliferation and apoptosis in islets are be-
ing progressively identified (Garcia-Ocana et al., 2001; Nielsen
et al., 2001), underlying molecular mechanisms and target
genes remain largely unknown. The present work provides evi-
dence that Pax4 functions as mediator of mitogen-induced
 -cell replication by orchestrating the activation of key factors
such as c-myc and Bcl-xL.
Consistent with several reports, we detected Pax4 transcript
in adult islets but not in the liver. Furthermore, a recent paper has
demonstrated that EGFP
   -cells could be FACS purified from a
transgenic mouse model harboring the EGFP cDNA under the
control of the Pax4 gene promoter (Theis et al., 2004). These re-
sults clearly demonstrate that the promoter is active in mature
 -cells and corroborates the detection of the Pax4 transcript.
The importance of Pax4 in  -cell proliferation was high-
lighted in this work using pharmacological and molecular ap-
proaches. A concomitant increase between Pax4 mRNA levels
and cell proliferation was found in islets treated with activin A
and betacellulin. These mitogens were shown to influence is-
let proliferation and differentiation (Demeterco et al., 2000).
Prentki and coworkers have demonstrated that the proliferative
effects of betacellulin and of glucagon-like peptide 1 in  -cells
are mediated by PI3-kinase and two of its downstream targets,
p38 MAPK and PKC  (Buteau et al., 2001, 2003). In our work,
wortmannin suppressed betacellulin-induced Pax4 expression,
implicating the PI3-kinase in this signaling pathway leading to
Pax4 activation and subsequent proliferation.
In agreement with published studies,  2.5% of  -cells
were proliferating in islets cultured in the presence of 10% FCS
and 11.5 mM glucose (Scharfmann et al., 1990). Adenoviral-
mediated overexpression of Pax4 in rat islets resulted in a more
than threefold increase in replication, whereas overexpression
of Pax6 and neurogenin3 had no effect. Consistent with the pu-
tative proliferative role of Pax4, other members of the Pax fam-
ily were shown to stimulate cell replication. For instance, in-
creased levels of Pax3 were observed in human tumors of
neural crest origin, whereas Pax2 expression was shown to be
indispensable for survival of ovarian and bladder cancer cell
Figure 8. Doxycycline-induced Pax4 stimulates
 -cell proliferation in human islets. (A) Prolif-
eration was measured by BrdU incorporation
in dispersed islets expressing either Pax4 wt
or R129W. Islets were cultured with or with-
out 0.5  g/ml of doxycycline in the presence
of 10  M BrdU. Immunocytochemical detec-
tion of BrdU incorporation (green) and nuclei
staining (DAPI in blue) was performed 48 h
later. (B) Forced expression of Pax4-induced
proliferation in human islet  -cell replication
as assessed by costaining of BrdU and insulin
(arrows). Bars, 50  M.JCB • VOLUME 167 • NUMBER 6 • 2004 1132
lines (Muratovska et al., 2003; Parker et al., 2004). Interest-
ingly, Pax5 was identified as a key factor for the maintenance
of the tumorigenic phenotype of neuroblastoma, whereas its re-
pression resulted in extensive self-renewal of B cell clones in
mice (Schaniel et al., 2002; Baumann Kubetzko et al., 2004).
These studies emphasize the critical role of Pax members in
cell growth with actions depending on the cellular context.
An increase in c-myc mRNA levels as well as its down-
stream target Id2 accompanied pax4-induced  -cell prolifera-
tion. This member of the Id family is a dominant-negative
protein that sequesters the retinoblastoma protein pRb, thus
preventing the antiproliferative effect of the tumor suppressor
protein (Lasorella et al., 2000). The importance of this pathway
was recently demonstrated by showing that suppression of
E2F, a target of pRB, results in impaired pancreatic growth and
 -cell mass (Fajas et al., 2004). Paradoxically, activation of
c-myc in mature  -cells was shown to induce  -cell prolifera-
tion and simultaneously promote apoptosis that rapidly erodes
 -cell mass (Laybutt et al., 2002; Pelengaris et al., 2002). Con-
current overexpression of Bcl-xL in these  -cells converted
c-myc from an apoptotic gene to a growth inducer (Pelengaris
et al., 2002). Consistent with these studies, we found a sus-
tained increase in Bcl-xL gene expression, which may thus pro-
tect  -cells from apoptosis. Although increases in Bcl-xL tran-
scripts were relatively modest, similar levels were shown to
protect islet  -cells from thapsigargin-induced apoptosis (Zhou
et al., 2000). We confirmed by transient transfection assays that
Pax4 stimulates c-myc and Bcl-xL gene promoter activities.
More importantly, we demonstrate that the mutation in the
paired DNA binding domain of Pax4, which has been linked to
type 2 diabetes, was less efficient in transactivating both genes.
A precedent for Bcl-xL transcriptional regulation by Pax fam-
ily members exists in that Pax3 binds and transactivates the
promoter of this gene (Margue et al., 2000).
Normal nutrient-stimulated insulin release is initiated by
mitochondrial ATP production. This causes the closure of
ATP-dependent K
  channels, plasma membrane depolarization
promoting an increase in cytosolic Ca
2 , which is the main trig-
ger for exocytosis (Maechler and Wollheim, 2001; Wollheim
and Maechler, 2002). Rises in cytosolic Ca
2  are relayed to the
mitochondria and reflect  -cell activation (Kennedy et al., 1996;
Ishihara et al., 2003). We found that total ATP levels and rest-
ing [Ca
2 ]m were markedly higher in Pax4-transduced islets.
Similar alterations in total ATP levels were reported in a mouse
model overexpressing Bcl-xL in  -cells as well as in cardio-
myocytes treated with IGF-1 (Zhou et al., 2000; Yamamura et al.,
2001). Furthermore, Bcl-xL has recently been shown to induce
ion channel activity in mitochondria (Jonas et al., 2003) pro-
viding an explanation for the elevated [Ca
2 ]m. Thus, increased
Bcl-xL may render  -cells refractory to further stimulation by
nutrients. Indeed, glucose-evoked increases in both cytosolic
ATP generation and [Ca
2 ]m were attenuated in Pax4-overex-
pressing islets, indicating that perhaps Bcl-xL rather than Pax4
is directly responsible for blunted glucose-induced insulin se-
cretion. Despite the elevated total ATP content, basal cytosolic
ATP levels were drastically reduced in Pax4-expressing islets
indicating defective ATP transport across the mitochondrial
membrane. However, mRNA levels for the predominant trans-
porter of ATP, the adenine nucleotide translocase (ANT1), were
unaltered (unpublished data), suggesting other consequences of
Bcl-xL up-regulation. Therefore, Pax4-stimulated Bcl-xL ex-
pression may confer protection against cell death prone to
c-myc expression while concomitantly impeding insulin secre-
tion by altering mitochondrial signaling. Incidentally, the raised
mitochondrial ATP concentration will inhibit pyruvate dehy-
drogenase activity and force pyruvate carbons toward pyruvate
carboxilase and the anaplerosis pathway. Such a shift was
shown to allow normal or even increased CO2 production from
glucose despite attenuated PDH activity, providing an expla-
nation for normal steady-state levels of glucose oxidation in
Pax4-overexpressing islets (Liu et al., 2004).
A major finding of this work was the capacity of Pax4 to
also promote  -cell replication and survival in human islets.
Doxycycline-inducible adenoviral vectors allowed us to con-
vincingly show that the wt Pax4 upon drug stimulation pro-
moted proliferation and protected islet cells from cytokine-
induced apoptosis, whereas the mutant was less efficacious. Of
note, it was recently demonstrated that estrogen-stimulated Bcl-
xL expression in neurons protects against cytokine-induced
apoptosis reinforcing the potential involvement of Bcl-xL in is-
let cell survival (Koski et al., 2004). Furthermore, Pax4 levels
Figure 9. Doxycycline-stimulated Pax4 expression protects human islets
from cytokine-induced apoptosis. Islets were infected with either Ad-mPax4-
myc wt (A) or R129W (B) as described in Materials and methods and
cultured for 24 h with the indicated concentrations of doxycycline. Islets
were subsequently treated for 24 h with IFN- , IL-1 , and TNF-  (2 ng/ml
each) to promote apoptosis. Cell death was measured by the TUNEL assay.
More than 700 cells were counted for each condition. *, P   0.05; **,
P   0.01. An ANOVA with Bonferroni/Dunn post hoc analysis between
Pax4 wt and R129W revealed a statistical significance of P   0.00245 at
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were maintained close to physiological ranges providing for a
specific effect of the transcription factor on proliferation and
cell survival. Thus, by modulating apoptosis through Bcl-xL
expression and proliferation via c-myc levels, Pax4 may regu-
late the total population of  -cells and ultimately islet mass.
A recent paper has shown that pancreatic  -cells are
replenished exclusively from preexisting mature islet  -cells
rather than from precursor cells without providing a molecular
mechanism (Dor et al., 2004). We propose in the current study
that Pax4 operates as a key regulator of adult  -cell mass by or-
chestrating the replicating effect of several signal transduction
pathways toward the c-myc/Id2 cascade. We further suggest
that Pax4 induces Bcl-xL in parallel, thus preventing c-myc–
induced apoptosis to the detriment of insulin secretion (see pro-
posed model, Fig. 6 D). Down-regulation of Bcl-xL by RNA in-
terference should confirm this specific protective function.
However, we cannot exclude the involvement of other potential
anti- or proapoptotic genes in Pax4-induced  -cell survival, a
quest that we are currently investigating. The involvement of
Pax4 mutations in the development of type 2 diabetes (Shimajiri
et al., 2001, 2003; Kanatsuka et al., 2002) and haplotype associ-
ation with type 1 diabetes (Holm et al., 2004) could be linked to
the failure of islets to compensate for the loss of  -cells aggra-
vated by additional genetic and environmental factors.
Materials and methods
Islet isolation and culture
Pancreatic islets were isolated from Wistar rats as described previously
(Gauthier et al., 2004). In several instances, islets were exposed to 0.1,
0.5, and 2 nM of activin A, betacellulin, and TGF- 1 as well as 50 or
100 nM of wortmannin (Sigma-Aldrich) for 24 h. Freshly isolated human
islets, obtained from D. Bosco (The Cell Isolation and Transplantation Lab-
oratory, Geneva, Switzerland), were maintained in CMRL-1066 supple-
mented with 10% FCS, 100 U/ml penicillin, 100  g/ml streptomycin,
and 100  g/ml gentamycin for 2–4 d before experiments.
Plasmid and adenovirus constructions
The full-length mouse Pax4 cDNA was amplified by PCR and the product
was cloned into the expression vector pcDNA3.1/myc-His (Invitrogen).
The Pax4-myc wt was subjected to mutagenesis to generate mutant Pax4-
myc R129W (arginine at codon 129 to tryptophan). The mouse mutant
R129W of pax4 gene was shown to correspond to the human mutation
R121W (Shimajiri et al., 2001). Subsequently, wt and mutant Pax4-myc
cDNAs were subcloned into the pTRE-Shuttle2 vector (CLONTECH Labora-
tories, Inc.). The inducible cassettes were transferred into the Adeno-X viral
DNA to generate recombinant adenoviruses (Ad-mPax4-myc wt and Ad-
mPax4-myc R129W).
Adenoviral infection of islets
The recombinant adenoviruses AdCMVPax4IRESGFP, AdCMVNgn3IRESGFP,
and AdCMVPax6 were provided by L. St-Onge (DeveloGen AG, Göttin-
gen, Germany). AdCAlacZ, containing the bacterial  -galactosidase
cDNA, was used as control (Ishihara et al., 1999). Rat islets were infected
with various amounts of recombinant adenoviruses (as indicated in fig-
ures) for 90 min, washed, and replenished with fresh medium. Human is-
lets were coinfected with either Ad-mPax4-myc wt or Ad-mPax4-myc
R129W along with the adenoviral construct harboring the tetracycline
transcriptional activator (Ad-X Tet-On) at a ratio of 2:1 (3.6   10
7 pfu/ml
of total viral particles). Cells were rinsed 90 min after infection and cul-
tured in fresh media supplemented with the indicated concentration of
doxycycline.
Quantitative RT-PCR
Total RNA from 50 islets was extracted using the Trizol reagent (Invitro-
gen) and 2  g were converted into cDNA as previously described (Gau-
thier et al., 1999b). Primers for cyclophilin, somatostatin, glucagon, insulin,
Pdx1, c-myc, Id2, Bcl-xL, Bcl-2, Pax4, and caspase 3 were designed using
the Primer Express Software (Applera Europe). Quantitative RT-PCR was
performed described as previously (Gauthier et al., 2004).
Transient transfection assays
The c-myc (pDEL-1-Luc), Bcl-xL (Bcl-xL/515), and telomerase (pTERT-luc)
gene promoter luciferase reporter constructs were provided by B. Vogel-
stein (The Johns Hopkins Oncology Center, Baltimore, MD), B. Schaefer
(University of Zurich, Zurich, Switzerland), and R. Dalla-Favera (Columbia
University, New York, NY), respectively. The BHK-21 cell line was tran-
siently transfected using the calcium phosphate precipitation technique as
described previously (Gauthier et al., 1999a). The pSV- -galactosidase
control vector (Promega) was used as internal control to normalize for
transfection efficiency ( 15%) in all experiments. Values correspond to
the mean and standard error of at least four to five individual transfections
performed in duplicates. Results are presented as fold induction of the con-
trol sample obtained from cells transfected with empty expression vector.
Nuclear extract preparation and EMSA
Nuclear protein extracts and DNA binding assays were performed as de-
scribed previously (Gauthier et al., 2002). Recombinant Pax4 as well as
Pax6 were prepared using an in vitro transcription and translation system
as described by the manufacturer (Promega). Antibodies generated
against Pax4 and Pax6 were provided by M.S. German (University of
California, San Francisco, San Francisco, CA) and S. Saule (Institut Curie,
Orsay Cedex, France), respectively.
Hormone radioimmunoassays
Insulin secretion from 15 matched-size islets per condition was measured
over a period of 30 min in Krebs-Ringer bicarbonate Hepes buffer contain-
ing the indicated stimulators. Insulin radioimmunoassays were performed as
outlined previously (Gauthier et al., 2004). Secreted insulin was expressed
as a percentage of total cellular insulin content. Glucagon radioimmunoas-
says were adapted from a protocol derived from Salehi et al. (1999).
Glucose oxidation and ATP production
Carbon dioxide production derived from glucose oxidation was measured
using the multiwell 
14CO2-capture assay developed by Collins et al. (1998).
ATP measurements were performed as previously outlined (Gauthier et al.,
2004).
Mitochondrial calcium measurements
Islets were infected with rAdRIP-maequorin (4.8   10
7 pfu/ml) and either
AdCaLacZ or AdCMVPax4IRESGFP (2.4   10
7 pfu/ml) for 90 min. Islets
were washed and seeded onto A431 extracellular matrix-coated cover-
slips (Ishihara et al., 2003). Coverslips were placed in a sealed, thermo-
statted (37 C) chamber, 5 mm from a photonmultiplier, which was used to
detect emitted luminescence, as previously described (Kennedy et al.,
1996). Islets were superfused (1.0 ml min
 1) with Krebs-Ringer bicarbon-
ate Hepes buffer supplemented with either 16.7 mM glucose or 60 mM
KCl where indicated. Luminescence output was recorded every second us-
ing a photon-counting board (model C660; Thorn EMI) after a 30-min
equilibration period to establish the baseline. Recorded counts were con-
verted to [Ca
2 ]m as published elsewhere (Challet et al., 2001).
Immunohistochemistry
Islets or single cell suspensions were cultured on polyornithine-treated
glass coverslips for 2 d, washed with PBS, and fixed in 4% PFA in PBS for
20 min at RT. Recombinant Pax4 wt or R129W myc-tagged proteins as
well as doxycycline-dependent activation of PAX4 were visualized by im-
munohistochemistry using an antibody against the myc epitope (dilution
1:200; Invitrogen). Immunochemical detection of  -cells was performed as
described previously (Ishihara et al., 2003). Nuclei were stained with 10
 g/ml DAPI (Sigma-Aldrich). Coverslips were mounted using fluorescent
mounting medium (DakoCytomation) and visualized using an Axiophot I
(Carl Zeiss MicroImaging, Inc.).
Cell proliferation and TUNEL assays
For proliferation, 24 h before fixation, infected or mitogen-treated cells
were labeled with 10  M BrdU. Proliferation was estimated using an im-
munohistochemical assay kit as described by the manufacturer (BrdU la-
beling and detection kit; Roche). Cells were also costained for insulin as
described, and results are expressed as a percentage of BrdU/insulin-pos-
itive cells over the total amount of insulin-positive cells. Alternatively, hu-
man islets were cultured with or without doxycycline for 24 h after infec-
tion and incubated for 24 h in the presence of IFN- , IL-1 , and TNF-  (2JCB • VOLUME 167 • NUMBER 6 • 2004 1134
ng/ml each) to promote apoptosis. Cell death was measured by the
TUNEL assay (In Situ Cell Death Detection Kit; Roche). Results are ex-
pressed as a percentage of fluorescein-labeled nuclei (TUNEL-positive
cells) over the total amount of islet cells (nuclei staining by DAPI).
Statistical analysis
Results are expressed as mean   SEM. Where indicated, the statistical
significance of the differences between groups was estimated by unpaired
t test. * and ** indicate statistical significance with P   0.05 and P  
0.01, respectively. In some instances, ANOVA with Bonferroni/Dunn post
hoc analysis was performed.
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